[Directly hit the leading area] Based on Pudong's continuous "beauty" innovation!Shiseido Ziyue Fund officially launched

Author:Pudong Observation Time:2022.08.11

300万合成-3.gif

On August 10, Shiseido China announced that the Ziyue Fund, which was exclusively contributed, completed the relevant regulatory filing. The first spent on nearly 100 million yuan, led the reorganization of collagen biomagon, leading enterprise Jiangsu Chuangjian Medical Technology Co., Ltd. ("Chuangjian Medical" for short ) Series A financing.

Ziyue Fund is a special investment fund of China's first international beauty group. It is established by Shiseido and the leading domestic asset management company Boyu Investment. Focus on the emerging brands such as beauty, health and other emerging brands and upstream and downstream related technology companies. Investment Opportunities.

Shiseido China said that he hopes to lay out new biological materials for beauty in advance, and plans to explore the cooperation space for functional skin care products in combination with the advantages of product development, raw materials supply and channel resources of both parties. At the same time, Ziyue Fund's investment will help Chuangjian medical treatment to further consolidate the leading advantage in the critical period of reorganization of collagen development.

At present, functional skin care products are favored by more and more consumers, including anti -sensitivity, anti -aging, strong efficacy, pure skin, and refined management of medical art. Subtraction between deployment.

With the development of the Chinese beauty market, the growth of emerging areas has been among the best globally. Many rising outstanding local companies are continuously entering "fresh blood" to the industry with vigorous innovation.

As a leading enterprise for reorganizing collagen biomass materials, Chuangjian Medical pays attention to independent innovation research and development, and realizes the two major technologies: "Construction of Reorganizing III Collagen Yeast Stable Genetic expression System" and "30 -ton stable fermentation purification technology development". The completion of the scale and standardized production of the reorganization I, II, III, and XVII collagen has filled the global "ton" capacity for more than 30 years in the field of global restructuring collagen materials. At the same time It has also achieved a breakthrough in R & D and industrialization of this special type of collagen material "from 0 to 1", providing a new direction for renewable material -type innovative medical devices.

Chuangjian Medical, as one of the "YY/T1849 Reorganization Collagen" (2022) drafting units, has authorized/applied for more than 40 patents, and has been approved for reorganization of more than 30 types of collagen. In 2022, Chuangjian Medical's cumulative 4 three types of certificates entered the clinical trial stage and will soon enter the product registration stage.

Qian Song, CEO of Chuangjian Medical, said: "Ziyue Fund's led investment is a powerful endorsement of Chuangjian Medical, accelerating the pace of corporate research and development and development of the international market. I hope to join hands with Shiseido to open up a wider business area and use Shiseido to use Shiseido Management experience and global networks are on a larger international stage, leading China's reorganization collagen to lead the global preemptive opportunity. "

Shiseido was established in 1872 and currently has business in more than 120 countries and regions around the world. In 1981, Shiseido entered the Chinese market as the first international cosmetics group. As the earliest batch of foreign -funded enterprises to enter China, Raccion has been growing with the Chinese cosmetics market, and has actively promoted the development and progress of the Chinese cosmetics industry. On January 1, 2017, Shiseido China Headquarters was established in Pudong.

Shiseido China CEO Fujiwara Kato said: "As the earliest international beauty group to enter China, Shiseido has been based on China for more than 40 years and has always believed in the huge potential of the Chinese market and has never shaken the confidence to invest in China. We have a strong manifestation of China's long -term commitment. As a new starting point for Shiseido to integrate local innovation, we hope to focus on the blessing of brand management experience and research and development strength, focus on the development of a functional skin care field with huge potential, and join forces with Chuangjian Medical and further promote further promotion The high -quality development of China's beauty industry. "

It is reported that Ziyue Fund will assist Shiseido China to fully reach various startups, improve the business ecosystem, and make forward -looking deployment for better service in the future.

Responsible editor Ni Liqi

Text Yang Zhenying

- END -

The IPO application of the Cavaliers Dairy Beijing Stock Exchange is accepted, and the income mainly comes from Inner Mongolia Autonomous Region

On July 4th, Capital State learned that the IPO application of the Cavaliers Dairy...

Removal tax refund expansion will be implemented on July 1 to apply for eligible enterprises to apply today

Chen Yongkang Cover Journalist Liu XuqiangAccording to the Announcement on the Sco...